What is Bio-Gene Technology?
Bio-Gene Technology, based in Melbourne, Australia, is a biotechnology company focused on developing a patent-protected product platform utilizing the -triketone chemical class for novel insecticides. The company's lead molecule, FLAVOCIDE, is a chemically synthesized, nature-identical flavesone, derived from research into natural product-based insecticides found in Australian flora. The company operates within the agricultural technology and pest control sectors, aiming to provide innovative solutions for insect management.
How much funding has Bio-Gene Technology raised?
Bio-Gene Technology has raised a total of $2.4M across 1 funding round:
Share Placement
$2.4M
Share Placement (2020): $2.4M, investors not publicly disclosed
What's next for Bio-Gene Technology?
The recent major strategic investment positions Bio-Gene Technology for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, scale up production capabilities for FLAVOCIDE, and support broader commercialization efforts. The company's focus on a unique chemical class and its patent protection suggests a strategy aimed at capturing a significant share of the global insecticide market, potentially moving towards enterprise-level partnerships or further funding rounds to support its expansion.
See full Bio-Gene Technology company page
